Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07577583
Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel
Sponsor: TG Therapeutics, Inc.
View on ClinicalTrials.gov
Summary
The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.
Official title: Long-term Follow-up (LTFU) of Study Participants Who Received Azer-Cel, An Allogeneic Chimeric Antigen Receptor T-Cell Product, in a TG Therapeutics, Inc., Clinical Study
Key Details
Gender
All
Age Range
18 Years - 62 Years
Study Type
OBSERVATIONAL
Enrollment
32
Start Date
2027-05-01
Completion Date
2039-12-01
Last Updated
2026-05-11
Healthy Volunteers
No
Conditions
Interventions
OTHER
No Intervention
No Intervention